86 results
S-8
VERV
Verve Therapeutics Inc
27 Feb 24
Registration of securities for employees
8:32am
on March 14, 2022, and including any amendments and reports filed for the purpose of updating such description.
All documents subsequently filed … ) of the Exchange Act that are incorporated by reference in the registration statement.
(2) That, for the purpose of determining any liability under
S-8
VERV
Verve Therapeutics Inc
27 Feb 24
Registration of securities for employees
8:32am
(the “ESPP”) and (iii) 4,000,000 shares issuable under the 2024 Inducement Stock Incentive Plan (the “Inducement Plan”).
Estimated solely for the purpose
S-8
EX-99.3
VERV
Verve Therapeutics Inc
27 Feb 24
Registration of securities for employees
8:32am
Exhibit 99.3
Verve Therapeutics, Inc.
2024 INDUCEMENT STOCK INCENTIVE PLAN
1. Purpose
The purpose of this 2024 Inducement Stock Incentive Plan
8-K
EX-1.1
j7dql29hs53
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
8-K
xsfhi3enyfq
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
424B5
v6j 3abzp
29 Nov 23
Prospectus supplement for primary offering
4:47pm
424B5
z2ipb fa60hcmed8
28 Nov 23
Prospectus supplement for primary offering
4:25pm
8-K
1fsi7 gbu
15 Jun 23
Entry into a Material Definitive Agreement
6:37am